Resmed Inc. buy Needham & Company LLC
Start price
25.01.24
/
50%
€173.80
Target price
25.01.25
€197.59
Performance (%)
17.29%
Price
02.05.24
€203.40
Summary
This prediction is currently active. The BUY prediction by Needham___Company_LL currently has a performance of 17.29%. A total of €0.45 was paid as dividends for this prediction. This prediction currently runs until 25.01.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | 18.947% | 18.947% |
| iShares Core DAX® | 0.000% | -2.064% |
| iShares Nasdaq 100 | 0.626% | -2.884% |
| iShares Nikkei 225® | 1.568% | -5.892% |
| iShares S&P 500 | 0.334% | -2.281% |
Comments by Needham___Company_LL for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at Needham & Company LLC from $180.00 to $215.00. They now have a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat